Fundraising Fox
Find your path to Chong
Sign up to see every warm intro you have to Chong
- Paths you didn't know you had: your email and LinkedIn already hold routes to Chong. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Chong Xu is a Partner at F-Prime focused on biopharmaceutical and medical technology, and collaborates with the Eight Roads Ventures Asia team on portfolio and investment opportunities in China. He joined F-Prime in 2015 after roles at McKinsey, hedge funds Massif Partners and Affirmed Healthcare, and neurobiology research at Temasek Life Sciences Laboratory; he holds a PhD in Cell Biology and an MBA from the University of Virginia and a biology degree from Zhejiang University.
Invests in
BiotechMedical Devices
Investments
Investor
AlphaGen TxK36 TherapeuticsK36 TxOncusp TherapeuticsPediatrixR1 TherapeuticsRareStone GroupRareStone Group (Previously Citrine Medicine)SironaxSkyline TxTandemai
Sources: the firm's website · curated public sources.
Colleagues at F-Prime Capital
Network6
Investors connected to Chong in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Chong Xu?
- Chong Xu is a Partner at F-Prime focused on biopharmaceutical and medical technology, and collaborates with the Eight Roads Ventures Asia team on portfolio and investment opportunities in China. He joined F-Prime in 2015 after roles at McKinsey, hedge funds Massif Partners and Affirmed Healthcare, and neurobiology research at Temasek Life Sciences Laboratory; he holds a PhD in Cell Biology and an MBA from the University of Virginia and a biology degree from Zhejiang University.
- Where does Chong Xu work?
- Chong Xu is Partner at F-Prime Capital.
- What does Chong Xu invest in?
- Chong Xu invests in Biotech, Medical Devices.
- What check size does Chong Xu write?
- Chong Xu typically writes checks of $100K – $10M.
- What boards does Chong Xu sit on?
- Chong Xu holds tracked board seats at Adagene, Innovent, OnCusp Tx, Remunix, Semma Tx, Shinobi Tx, Sironax.
- What companies has Chong Xu invested in?
- Investments tracked here include AlphaGen Tx, K36 Therapeutics, K36 Tx, Oncusp Therapeutics, Pediatrix, R1 Therapeutics, RareStone Group, RareStone Group (Previously Citrine Medicine), Sironax, Skyline Tx, Tandemai.
About this profile. Compiled from public sources — F-Prime Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights